Retirement Planning Company of New England’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
Retirement Planning Company of New England's NVAX Position: Q1 2022 in Review
Retirement Planning Company of New England sold out of Novavax (NVAX) in Q1 2022, closing a stake of 42 shares — an estimated $6K sold.
Retirement Planning Company of New England first reported a position in NVAX in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.
- Retirement Planning Company of New England reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
- Retirement Planning Company of New England sold 42 Novavax shares in Q1 2022, an estimated $6K.
- Retirement Planning Company of New England first reported a position in Novavax in Q4 2021 and held it in 1 quarter.
- Retirement Planning Company of New England's Novavax position peaked at $6K in Q4 2021.
- 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.
Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.